Driving Pressure in Laparoscopic Surgery
Launched by CAPITAL MEDICAL UNIVERSITY · Apr 30, 2020
Trial Information
Current as of August 20, 2025
Completed
Keywords
ClinConnect Summary
After screened for preoperative risk factors, 48 patients undergoing elective laparoscopic surgery and planned to be extubated in the operating room are randomly assigned to two groups: (1) PEEP = 5cmH2O; (2) driving pressure (DP)-guided PEEP. The ventilation protocol consists of volume-controlled mechanical ventilation (Datex Ohmeda S/5 Advance; General Electric Company Healthcare, Helsinki, Finland) at a tidal volume (VT) of 8 ml/kg predicted body weight (PBW), fresh gas of 2 litre /min, inspiratory to expiratory ratio of 1:2, and a respiratory rate adjusted to normocapnia (arterial carbo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent has been obtained
- • Elective laparoscopic surgery with Trendelenburg position
- • Expected ventilation duration \> 2 hours
- • Scheduled to be extubated in the operation
- Exclusion Criteria:
- • Mechanical ventilation of \> 1 hour within the last 2 weeks before surgery
- • Body mass index ≥ 35 kg/m2
- • Acute respiratory failure (pneumonia, acute lung injury or acute respiratory distress syndrome)
- • Emergency surgery
- • Severe cardiac disease
- • Progressive neuromuscular illness
- • Pregnancy
- • Refusal to participate
- • Contradicted to EIT scan
About Capital Medical University
Capital Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with a network of healthcare professionals and researchers to drive breakthroughs in medical science. Capital Medical University aims to enhance patient care and improve health outcomes by fostering a multidisciplinary approach to clinical research, ensuring that its trials are designed to address critical health challenges and contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Ruquan Han, MD,PHD
Study Director
Beijing Tiantan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials